)
Edge14 Aug 2026
Deutsche Qualität: The Story of Birkenstock
From an 18th-century German shoemaker to a global footwear brand, how Birkenstock turned an orthopedic insole into the world's most popular sandal.
Lincoln Pharmaceuticals
Lincoln Pharmaceuticals (531633) investor relations material
Lincoln Pharmaceuticals Q1 26/27 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 26/27 earnings summary13 Aug, 2026
Executive summary
Consolidated net profit for Q1 FY27 reached Rs. 36.23 crore, up 30.90% year-over-year, with total income rising 19.02% to Rs. 201.55 crore and EBITDA increasing 32.29% to Rs. 51.70 crore.
The company targets Rs. 1,000 crore revenue over the next three years, aiming for 15-18% annual growth, driven by strong performance in cardiac, diabetic, dermatology, and ENT segments.
Exports span 60+ countries, with plans to expand to 90 countries in 2-3 years, supported by regulatory approvals in Canada, EU, and Australia.
Financial highlights
Q1 FY27 total income: Rs. 201.55 crore (up 19.02% YoY); EBITDA: Rs. 51.70 crore (up 32.29% YoY); net profit: Rs. 36.23 crore (up 30.90% YoY); EPS: Rs. 18.09.
FY26 total income: Rs. 704.48 crore (up 9.10% YoY); EBITDA: Rs. 131.14 crore (up 5.78% YoY); net profit: Rs. 87.89 crore (up 6.74% YoY); dividend of Rs. 1.80 per share recommended.
Standalone and consolidated results for Q1 FY27 show similar trends, with revenue from operations at Rs. 177.28 crore and net profit at Rs. 36.23 crore.
Outlook and guidance
Management reiterates focus on operational efficiency, portfolio expansion, and disciplined execution to achieve Rs. 1,000 crore revenue and sustainable growth.
Plans to expand presence in regulated and semi-regulated markets, leveraging recent regulatory approvals and manufacturing capabilities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Lincoln Pharmaceuticals
- FY26 net profit up 6.74% to Rs. 87.89 crore; revenue rises 9.10% to Rs. 704.48 crore.531633
Q4 25/26 - Q3 FY26 net profit surged 37.70% year-over-year, with strong revenue and margin growth.531633Q3 25/26
- Q2 FY26 net profit dropped 24% YoY; company targets Rs. 1,000 crore revenue in 3 years.531633Q2 2026
- Q1 FY26 net profit rose 16.93% YoY, with robust growth and ambitious expansion targets.531633Q1 25/26
- Quarterly net profit increased to ₹2,633.03 lakhs, with EPS at ₹13.15.531633Q2 24/25
- Strong revenue and profit growth with higher EPS, driven by pharmaceutical business momentum.531633Q1 24/25
- Net profit fell 11.7% in FY25, but revenue grew 5% and FII holding reached 5%.531633Q4 24/25
- Net profit declined in Q3 FY25, but revenue growth and global expansion remain on track.531633Q3 24/25
Next Lincoln Pharmaceuticals earnings date
Q2 202712 Nov, 2026
Lincoln Pharmaceuticals
Next Lincoln Pharmaceuticals earnings date
Q2 202712 Nov, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage